CA
WST icon

Cetera Advisors’s West Pharmaceutical WST Stock Holding History

Cetera Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$866K Buy
2,189
+1,019
+87% +$377K 0.01% 1228
2023
Q4 		$412K Buy
1,170
+75
+7% +$26.5K 0.01% 1244
2023
Q3 		$411K Sell
1,095
-26
-2% -$10.1K 0.01% 1164
2023
Q2 		$429K Sell
1,121
-20
-2% -$7.14K 0.01% 1137
2023
Q1 		$395K Buy
1,141
+167
+17% +$48.8K 0.01% 1139
2022
Q4 		$229K Buy
+974
New +$231K ﹤0.01% 1377
2021
Q1 		– Sell
-960
Closed -$272K – 1251
2020
Q4 		$272K Sell
960
-100
-9% -$28.1K 0.01% 863
2020
Q3 		$291K Sell
1,060
-240
-18% -$63.5K 0.01% 745
2020
Q2 		$295K Buy
+1,300
New +$255K 0.01% 708

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Cetera Advisors's WST Position: Q1 2024 in Review

Cetera Advisors increased its West Pharmaceutical (WST) stake by 87% in Q1 2024, buying an estimated $377K and bringing the position to 2,189 shares worth $866K. The position accounts for 0.01% of the portfolio, ranked #1228.

Cetera Advisors first reported a position in WST in Q2 2020 and has held it in 9 quarters since. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Cetera Advisors held 2,189 shares of West Pharmaceutical worth $866K as of Q1 2024.
  • Cetera Advisors bought 1,019 West Pharmaceutical shares in Q1 2024, an estimated $377K.
  • West Pharmaceutical made up 0.01% of Cetera Advisors's portfolio in Q1 2024, its #1228 holding.
  • Cetera Advisors first reported a position in West Pharmaceutical in Q2 2020 and has held it in 9 quarters since.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.